Clinical Trial Results: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SGLT2 inhibitors for efficacy, mechanisms, and safety in kidney transplant recipients, including those with post-transplant diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipient Conditions
• Post-transplant Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Health Network, Toronto | Conditions: Kidney Transplant Recipients, Post-transplant Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2026-06-08